Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.

Yousif A KaririMichael S TossMansour AlsaleemKhloud A ElsharawyChitra JosephNigel P MonganAndrew R GreenEmad A Rakha

Published in: Breast cancer research and treatment (2022)

This study indicates that UBE2C is an independent prognostic biomarker in BC. These results warrant further functional validation for UBE2C as a potential therapeutic target in BC.

Keyphrases

risk assessment
human health
young adults